Rapport Therapeutics (RAPP) EPS (Basic) (2023 - 2026)
Rapport Therapeutics' (RAPP) quarterly EPS (Basic) came in at -$0.42 in Q1 2026, up 38.39% year-on-year from -$0.3 in Q1 2025, and up 51.52% on a QoQ basis from -$0.87 in Q4 2025.
Rapport Therapeutics (RAPP) EPS (Basic) (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of EPS (Basic) data on file, last reported at -$0.42 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 38.39% year-over-year to -$0.42 in Q1 2026; TTM through Mar 2026 was -$2.27, a 0.49% change from a year earlier, with the FY2025 full-year figure at -$2.86, up 24.17% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.42, up from -$0.87 in the prior quarter.
- Over the last five years, EPS (Basic) for RAPP reached as high as -$0.42 in Q1 2026 and fell as low as -$11.07 in Q1 2024.
- Historically, EPS (Basic) has averaged -$3.07 across 4 years, with a median of -$0.92 in 2024.
- On a YoY basis, EPS (Basic) climbed as much as 93.84% in 2025 and fell as far as 41.08% in 2025.
- Year by year, EPS (Basic) stood at -$8.98 in 2023, then soared by 89.27% to -$0.96 in 2024, then advanced by 9.99% to -$0.87 in 2025, then surged by 51.52% to -$0.42 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.42 in Q1 2026, -$0.87 in Q4 2025, and -$0.71 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Rapport Therapeutics | 1.94 Bn | 1.94 Bn | - | -0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.42 |
| Dec 31, 2025 | -0.87 |
| Sep 30, 2025 | -0.71 |
| Jun 30, 2025 | -0.75 |
| Mar 31, 2025 | -0.68 |
| Dec 31, 2024 | -0.96 |
| Sep 30, 2024 | -0.50 |
| Jun 30, 2024 | -1.70 |
| Mar 31, 2024 | -11.07 |
| Dec 31, 2023 | -8.98 |
| Sep 30, 2023 | -5.70 |
| Jun 30, 2023 | -4.45 |